Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Maria A. Turner"'
Autor:
Robin Eisch, Alexander Ling, Elaine S. Jaffe, H. Miles Prince, Stefania Pittaluga, John Wright, Richard Piekarz, Susan E. Bates, Sally Kennedy, Mark Kirschbaum, Seth M. Steinberg, Larisa J. Geskin, Louise C. Showe, Leslie Popplewell, David Joske, Edward W. Cowen, Caryn Steakley, Douglas R. Rosing, Jasmine Zain, David J. Liewehr, Thomas Litman, Maria L. Turner, Tito Fojo, Steven L. Allen, Jean Nichols
Publikováno v:
British Journal of Haematology. 170:96-109
Romidepsin is an epigenetic agent approved for the treatment of patients with cutaneous or peripheral T-cell lymphoma (CTCL and PTCL). Here we report data in all patients treated on the National Cancer Institute 1312 trial, demonstrating long-term di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1422f05d38230522af08f82c10f57d9
https://doi.org/10.1111/bjh.13400
https://doi.org/10.1111/bjh.13400
Autor:
Nicole E. Urquhart, Maria L. Turner, Thomas A. Waldmann, John E. Janik, Donn M. Stewart, Jonathan L. Berkowitz, John C. Morris, William D. Figg, Cody J. Peer, Elaine S. Jaffe, Maryalice Stetler-Stevenson, Joanna H. Shih, Gilian Wharfe, Thomas A. Fleisher, Carolyn K. Goldman
Publikováno v:
Clinical Immunology. 155:176-187
Interleukin-2 receptor α chain (CD25) is overexpressed in human T-cell leukemia virus 1 associated adult T-cell leukemia/lymphoma (ATL). Daclizumab a humanized monoclonal antibody blocks IL-2 binding by recognizing the interleukin-2 receptor α chai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99ce0afe0f47eab580a8a667d6f925b9
https://doi.org/10.1016/j.clim.2014.09.012
https://doi.org/10.1016/j.clim.2014.09.012
Autor:
Maria L. Turner, Seymour Rand, Rebat M. Halder, John J. Voorhees, Jonathan K. Wilkin, Lynn A. Drake, Howard I. Maibach, John J. DiGiovanna
Publikováno v:
Journal of the American Academy of Dermatology. 78:e77-e78
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::564da4385ddfc9fa00426f1281692752
https://doi.org/10.1016/j.jaad.2017.10.020
https://doi.org/10.1016/j.jaad.2017.10.020
Autor:
John I. Gallin, Maria L. Turner, Ivona Aksentijevich, Andrew P. Demidowich, Alexandra F. Freeman, Steven M. Holland, Douglas B. Kuhns, Daniel L. Kastner
Publikováno v:
Arthritis & Rheumatism. 64:2022-2027
Objective To describe the genotypes, phenotypes, immunophenotypes, and treatments of PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne), a rare autoinflammatory disease, in 5 patients. Methods Clinical information was gathered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efeddbe4844c05711e57771f5d762004
https://doi.org/10.1002/art.34332
https://doi.org/10.1002/art.34332
Autor:
Patrick R. Murray, Sean Conlan, Julia Oh, Clay Deming, Elizabeth A. Grice, Heidi H. Kong, Melony A. Beatson, Eric C. Polley, Julia A. Segre, Maria L. Turner, Effie Y.H. Nomicos, Nisc Comparative Sequence Program, Hirsh D. Komarow
Publikováno v:
Genome Research. 22:850-859
Atopic dermatitis (AD) has long been associated with Staphylococcus aureus skin colonization or infection and is typically managed with regimens that include antimicrobial therapies. However, the role of microbial communities in the pathogenesis of A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cfea4de664e6a10affee2f6a5e0d1c3
https://doi.org/10.1101/gr.131029.111
https://doi.org/10.1101/gr.131029.111
Autor:
Michael R. Bishop, Edward W. Cowen, Georgia B. Vogelsang, Kristin Baird, Steven Z. Pavletic, Sandra A. Mitchell, Leslie Lawley, Stephanie J. Lee, Jean Pierre Guadagnini, Matin M. Imanguli, Paul A. Carpenter, Janine A. Clayton, Javier Bolaños-Meade, Paul J. Martin, Mark M. Schubert, David A. Jacobsohn, Jane M. Fall-Dickson, Kimberly Powers, Bryce B. Reeve, Li Li, Maria L. Turner, Kevin L. Boyd, Michael Krumlauf, Lynn H. Gerber, Mary E.D. Flowers
Publikováno v:
Biology of Blood and Marrow Transplantation. 17(11):1619-1629
The lack of standardized criteria for measuring therapeutic response is a major obstacle to the development of new therapeutic agents for chronic graft-versus-host disease (cGVHD). National Institutes of Health (NIH) consensus criteria for evaluating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78188f7ee9a53f20b754411aee788ed9
Autor:
Maria (S) Turner
Publikováno v:
Fourth Genre: Explorations in Nonfiction. 13:91-97
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8c6c31512aed478055810c638cb9d2b
https://doi.org/10.1353/fge.2011.0006
https://doi.org/10.1353/fge.2011.0006
Autor:
Lindy P. Fox, Maria L. Turner, Neil S. Prose, Sarah T. Arron, Edward W. Cowen, Daniel D. Miller, Josephine C. Nguyen, Diana B. McShane
Publikováno v:
Journal of the American Academy of Dermatology. 62:31-37
Background Voriconazole is a broad-spectrum antifungal agent associated with photosensitivity and accelerated photoaging. A possible link with aggressive squamous cell carcinoma (SCC) has also been reported. Objective We sought to determine the incid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94f2e4bcd1023fa8ad24127cfdb2effe
https://doi.org/10.1016/j.jaad.2009.09.033
https://doi.org/10.1016/j.jaad.2009.09.033
Autor:
William D. Figg, Elaine S. Jaffe, Stephen Lade, Craig B. Reeder, John P. Leonard, John Wright, Maria L. Turner, Erin R. Gardner, A. Tito Fojo, Larisa J. Geskin, Robin Frye, H. Miles Prince, Maryalice Stetler-Stevenson, Mark Kirschbaum, Richard Piekarz, Steven L. Allen, Jasmine Zain, Susan E. Bates, David Joske, Seth M. Steinberg
Publikováno v:
Journal of Clinical Oncology. 27:5410-5417
Purpose Romidepsin (depsipeptide or FK228) is a member of a new class of antineoplastic agents active in T-cell lymphoma, the histone deacetylase inhibitors. On the basis of observed responses in a phase I trial, a phase II trial of romidepsin in pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28817a7b030ebc0ec426778e38b16d44
https://doi.org/10.1200/jco.2008.21.6150
https://doi.org/10.1200/jco.2008.21.6150
Autor:
Asha R. Patel, Barbara Wise, Kristin Baird, Maria L. Turner, Edward W. Cowen, Juan Gea-Banacloche, Sandra A. Mitchell, Steven Z. Pavletic
Publikováno v:
Biology of Blood and Marrow Transplantation. 15:370-376
Systemic fungal infections pose a significant risk to patients following allogeneic hematopoietic cell transplantation (alloHCT). Voriconazole (Vfend®, Pfizer) is an oral second-generation triazole antifungal agent that offers a broad spectrum of co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c2fbc7b4b74fc9b1ca8fafb93aeced
https://doi.org/10.1016/j.bbmt.2008.12.491
https://doi.org/10.1016/j.bbmt.2008.12.491